
浏览全部资源
扫码关注微信
纸质出版日期:2014
移动端阅览
张小玲, 张诗军, 徐成康. 加味少腹逐瘀汤联合灸法治疗原发性痛经55例[J]. 中国实验方剂学杂志, 2014,20(16):192-195.
ZHANG Xiao-ling, ZHANG Shi-jun, XU Cheng-kang. Jiawei Shaofu Zhuyu Decoction Combined with Moxibustion Therapy in Treating Primary Dysmenorrhea 55 Cases[J]. Chinese journal of experimental traditional medical formulae, 2014, 20(16): 192-195.
张小玲, 张诗军, 徐成康. 加味少腹逐瘀汤联合灸法治疗原发性痛经55例[J]. 中国实验方剂学杂志, 2014,20(16):192-195. DOI: 10.13422/j.cnki.syfjx.2014160192.
ZHANG Xiao-ling, ZHANG Shi-jun, XU Cheng-kang. Jiawei Shaofu Zhuyu Decoction Combined with Moxibustion Therapy in Treating Primary Dysmenorrhea 55 Cases[J]. Chinese journal of experimental traditional medical formulae, 2014, 20(16): 192-195. DOI: 10.13422/j.cnki.syfjx.2014160192.
目的: 探讨加味少腹逐瘀汤联合灸法治疗原发性痛经(PD)的近期和远期止痛效应及对血液流变学、前列腺素E2(PGF2)、前列腺素2α(PGF2α)的影响。 方法: 将108例完成随访的患者随机按数字表法分为对照组53例和观察组55例。两组研究分为导入期(第1个月经周期,D1)、治疗期(第2,3,4个月经周期,D2~4)和随访期(第5,6个月经周期,D5,D6)3个阶段。在导入期和随访期两组均采用阿司匹林泡腾片,0.5 g/次,必要时服用 。在治疗期,对照组采用阿司匹林泡腾片,0.5 g/次,3次/d,月经前3 d开始服用,直到月经来潮后1 d;观察组采用①加味少腹逐瘀汤内服,1剂/d,每月行经前5 d开始服药,服至月经来潮后1 d;②灸法,行经前3 d 开始,至月经来潮后2 d。记录D1~D6的痛经程度(VAS)、痛经持续时间及痛经症状评分;检测治疗前后血液流变学;检测治疗前后血清PGE2和PGF2α水平。 结果: 两组D2时点,VAS评分、痛经持续时间评分及痛经症状评分均较D1时点下降(P<0.01),两组D3,D4时点VAS评分、痛经持续时间评分及痛经症状评分均呈下降趋势;D5,D6时点两组VAS评分、痛经持续时间评分及痛经症状评分反弹,高于D4时点(P<0.01);观察组D2~D6时点VAS评分、痛经持续时间评分及痛经症状评分均低于对照组(P<0.01)。治疗后观察组全血黏度(高切、低切)、血浆黏度、全血还原黏度、纤维蛋白原和红细胞压积的改善均优于对照组(P<0.01);治疗后观察组PGE2高于对照组,PGF2α和PGF2α/PGE2低于对照组(P<0.01)。 结论: 加味少腹逐瘀汤联合灸法治疗原发性痛经近期、远期效应均显著,其作用机制可能与改善血液循环,调节前列腺素而发挥止痛效应有关。
Objective: Discuss near-term and forward analgesic effect of Jiawei Shaofu Zhuyu decoction combined with moxibustion therapy and influence to hemorheology
prostaglandin E2 (PGE2)and prostaglandin 2α (PGF2α) in treating primary dysmenorrhea(PD). Method: One hundred and eight patients who had by random number table were divided into control group (53 cases) and observation group (55 cases).Period of this study was divide into introduction period(the first menstrual cycle
D1)
cure period(the second
third and fourth menstrual cycle
D2-4) and follow-up period(the fifth and sixth menstrual cycle
D5 and D6). Patients in two groups were received aspirin effervescent tablets in introduction period and cure period
0.5 g/time
3 times/day
taken orally necessarily visual analogue scale(VAS≥5 scores). In cure period
patients in control group received aspirin effervescent tablets
0.5 g/time
3 times/day
and used at the third day before menstruation and stopt at the first day after menstruation.Patients in observation group received jiawei Shaofu Zhuyu decoction(taken orally)
1 dose/day
and used at the fifth day before menstruation and stopt at the first day after menstruation.moxibustion therapy used at the third day before menstruation and stopt at the second day after menstruation.Recording the degree of dysmenorrhea score(VAS)
duration of dysmenorrhea and symptoms of dysmenorrhea from D1 to D6.Before and after treatment
hemorheology was detected.And levels of serous of PGF2 and PGE2α were detected. Result: At the point-in-time of D2
compared with the point-in-time of D1
scores of VAS
duration and symptoms of dysmenorrhea in two groups decreased(P<0.01)
and at the point-in-time of D3 and D4
there was a decreasing trending of scores of VAS
duration and symptoms of dysmenorrhea in two groups.At the point-in-time of D5 and D6
scores of VAS
duration and symptoms of dysmenorrhea in two groups increased
and which were higher than those in two groups of the point-in-time of D4(P<0.01).And at the point-in-time of D2 to D6
scores of VAS
duration and symptoms of dysmenorrhea in observation group were lower than those in control group(P<0.01).After treatment
amelioration of whole blood viscosity(low shear and high shear)
plasma viscosity
whole blood reduced viscosity
fibrinogen and hematokrit in observation group were superior to those in control group(P<0.01).And levels of PGE2 in observation group was higher than in control group
but levels of PGF2α and PGF2α/PGE2were lower than those in control group (P<0.01). Conclusion: Jiawei Shaofu Zhuyu decoction combined with moxibustion therapy had significant near-term and forward analgesic effect in treating primary dysmenorrhea
the mechanism of action may be related to improving blood circulation
adjusting prostaglandin and giving play to analgesia effect.
0
浏览量
4
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621